Molecular biology of arrhythmic syndromes

Current Opinion in Cardiology

Volumn 15, Issue 1, 2000, Pages 12-22

  Vatta, Matteo ^a   Li, Hua ^a   Towbin, Jeffrey A ^a,b  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; ERYTHROMYCIN; KETOCONAZOLE; MACROLIDE; QUINIDINE; TERFENADINE; TRICYCLIC ANTIDEPRESSANT AGENT;

BRUGADA SYNDROME; GENE; GENE MAPPING; GENOTYPE; HEART VENTRICLE ARRHYTHMIA; HUMAN; LONG QT SYNDROME; MEDICAL GENETICS; MOLECULAR BIOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

BUNDLE-BRANCH BLOCK; CHROMOSOME MAPPING; ELECTROCARDIOGRAPHY; HUMANS; ION CHANNELS; LONG QT SYNDROME; MUTATION; SYNDROME;

EID: 0033979443     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-200001000-00003     Document Type: Review

References (101)

1. 1 Priori SG, Barhanin J, Hauer RNW, et al.: Genetic and molecular basis of cardiac arrhythmias: impact on clinical management (parts I and II). Circulation 1999, 99:518-528. Updated review of disorders resulting in cardiac arrhythmias.
2. 2 Brugada P, Brugada J: Right bundle-branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome: a multicenter report. J Am Coll Cardiol 1992, 20:1391-1396.
3. 3 Schwartz PJ, Locati EH, Napolitano C, Priori SG: The long QT syndrome. In Cardiac Electrophysiology: From Cell to Bedside. Edited by Zipes DP, Jalife J. Philadelphia: WB Saunders, 1996:788-811.
4. 4 Romano C, Gemme G, Pongiglione R: Antmie cardiache rare in eta pediatrica. Clin Pediatr 1963, 45:656-683.
5. 5 Ward OC: A new familial cardiac syndrome in children. J Ir Med Assoc 1964, 54:103-106.
6. 6 Priori SG, Napolitano C, Schwartz PJ: Low penetrance in the long-QT syndrome: clinical impact. Circulation 1999, 99:529-533. The first demonstration that low penetrance occurs in LQTS.
7. 7 Singer PA, Crampton RS, Bass NH: Familial Q-T prolongation syndrome: convulsive seizures and paroxysmal ventricular fibrillation. Arch Neurol 1974, 31:64-66.
8. 8 Ratshin RA, Hunt D, Russell RO Jr, Rackley CE: QT-interval prolongation, paroxysmal ventricular arrhythmias, and convulsive syncope. Ann Intern Med 1971, 75:19-24.
9. 9 Bellavere F, Ferri M, Guarini L, Bax G, Piccoli A, Cardone C, Fedele D: Prolonged QT period in diabetic autonomic neuropathy: a possible role in sudden cardiac death. Br Heart J 1988, 59:379-383.
10. 10 Ewing DJ, Boland O, Neilson JMM, Cho CG, Clarke BF: Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients. Diabetologia 1991, 34:182-185.
11. 11 Weintraub RG, Gow RM, Wilkinson JL: The congenital long QT syndromes in children. J Am Coll Cardiol 1990, 16:674-680.
12. 12 Marks ML, Trippel DL, Keating MT: Long QT syndrome associated with syndactyly identified in females. Am J Cardiol 1995, 10:744-745.
13. 13 Schwartz PJ, Segantini A: Cardiac innervation, neonatal electrocardiography and SIDS: a key for a novel preventive strategy? Ann N Y Acad Sci 1988, 533:210-220.
14. 14 Schwartz PJ, Stramba-Badiale M, Segantini A, et al.: Prolongation of the QT interval and the sudden infant death syndrome. N Engl J Med 1998, 338:1709-1714. Data implicating LQTS and sudden infant death syndrome.
15. 15 Jervell A, Lange-Nielsen F: Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death. Am Heart J 1957, 54:59-68.
16. 16 Towbin JA, Friedman RA: Prolongation of the long QT syndrome and sudden infant death syndrome. N Engl J Med 1998, 338:1760-1761.
17. 17 Jervell A: Surdocardiac and related syndromes in children. Adv Intern Med 1971, 17:425-438.
18. 18 James TN: Congenital deafness and cardiac arrhythmias. Am J Cardiol 1967, 19:627-643.
19. 19 Priori SG, Schwartz PJ, Napolitano C, et al.: A recessive variant of the Romano-Ward long-QT syndrome. Circulation 1998, 97:2420-2425.
20. 20 Keating MT, Atkinson D, Dunn C, Timothy K, Vincent GM, Leppert M: Linkage of a cardiac arrhythmia, the long QT syndrome, and the Harvey ras-1 gene. Science 1991, 252:704-706.
21. 21 Keating MT, Atkinson D, Dunn C, Timothy K, Vincent GM, Leppert M: Consistent linkage of the long QT syndrome to the Harvey ras-1 locus on chromosome 11. Am J Hum Genet 1991, 49:1335-1339.
22. 22 Towbin JA, Pagotto L, Siu B, et al.: Romano-Ward long QT syndrome (RWLQTS): evidence of genetic heterogeneity. Pediatr Res 1992, 31:23A.
23. 23 Benhorin J, Kalman YM, Madina A, et al.: Evidence of genetic heterogeneity in the long QT syndrome. Science 1993, 260:1960-1962.
24. 24 Curran ME, Atkinson D, Timothy K, et al.: Locus heterogeneity of autosomal dominant long QT syndrome. J Clin Invest 1993, 92:799-803.
25. 25 Towbin JA, Li H, Taggart T, et al.: Evidence of genetic heterogeneity in Romano-Ward long QT syndrome: analysis of 23 families. Circulation 1994, 90:2635-2644.
26. 26 Jiang C, Atkinson D, Towbin JA, et al.: Two long QT syndrome loci map to chromosome 3 and 7 with evidence for further heterogeneity. Nat Genet 1994, 8:141-147.
27. 27 Schott J, Charpentier F, Peltier S, et al.: Mapping of a gene for long QT syndrome to chromosome 4q25-27. Am J Hum Genet 1995, 57:1114-1122.
28. 28 Barhanin J, Lesage F, Guillemare E, Finc M, Lazdunski M, Romey G: KVLQT1 and IsK (minK) proteins associate to form the IKs cardiac potassium current. Nature 1996, 384:78-80.
29. 29 Sanguinetti MC, Curran ME, Zou A, et al.: Coassembly of KvLQT1 and minK (IsK) proteins to form cardiac IKs potassium channel. Nature 1996, 384:80-83.
30. Kr.
31. 31 Wang Q, Curran ME, Splawski I, et al.: Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet 1996, 12:17-23.
32. 32 Li H, Chen Q, Moss AJ, et al.: New mutations in the KVLQT1 potassium channel that cause long QT syndrome. Circulation 1998, :1264-1269.
33. 33 Choube C, Neyroud N, Guicheney P, Lazdunski M, Romey G, Barhanin J: Properties of KVLQT1 K+ channel mutations in Romano-Ward and Jervell and Lange-Nielsen inherited cardiac arrhythmias. EMBO J 1997, 16:5472-5479.
34. 34 Wollnik B, Schreeder BC, Kubish C, Esperer HD, Wieacker P, Jensch TJ: Pathophysiological mechanisms of dominant and recessive KVLQT1 K+ channel mutations found in inherited cardiac arrhythmias. Hum Mol Genet 1997, 6:1943-1949.
35. 35 Splawski I, Tristani-Firouzi M, Lehmann MH, Sanguinetti MC, Keating MT: Mutations in the minK gene cause long QT syndrome and suppress IKs function. Nat Genet 1997, 17:338-340.
36. 36 Warmke JE, Ganetzky B: A family of potassium channel genes related to eag in Drosophila and mammals. Proc Natl Acad Sci U S A 1994, 91:3438-3442.
37. 37 Arcangeli A, Rosati B, Cherubini A, et al.: HERG- and IRK-like inward rectifier currents are sequentially expressed during neuronal crest cells and their derivatives. Eur J Neurosci 1997, 9:2596-2604.
38. 38 Pennefather PS, Zhou W, Decoursey TE: Idiosyncratic gating of HERG-like K+ channels in microglia. J Gen Physiol 1998, 111:795-805.
39. 39 Bianchi L, Wible B, Arcangeli A, et al.: HERG encodes a K+ current highly conserved in tumors of different histogenesis: a selective advantage for cancer cells? Cancer Res 1998, 58:815-822.
40. 40 Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT: A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 1995, 80:795-803.
41. 41 Schulze-Bahr E, Haverkamp W, Funke H: The long-QT syndrome. N Engl J Med 1995, 333:1783-1784.
42. 42 Sanguinetti MC, Jiang C, Curran ME, Keating MT: A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell 1995, 81:299-307.
43. 43 Trudeau MC, Warmke J, Ganetzky B, Robertson G: HERG, a human inward rectifier in the voltage-gated potassium channel family. Science 1995, 269:92-95.
44. 44 Sanguinetti MC, Curran ME, Spector PS, Keating MT: Spectrum of HERG K+-channel dysfunction in an inherited cardiac arrhythmia. Proc Natl Acad Sci U S A 1996, 93:2208-2212.
45. 45 Furutani M, Trudeau MC, Hagiwara N, et al.: Novel mechanism associated with an inherited cardiac arrhythmia: defective protein trafficking by the mutant HERG (G601S) potassium channel. Circulation 1999, 99:2290-2294.
46. 46 Zhou Z, Gong Q, Miles L, et al.: HERG channel dysfunction in human long QT syndrome. J Biol Chem 1998, 263:21061-21066.
47. 47 McDonald TV, Yu Z, Ming Z, et al.: A MinK-HERG complex regulates the cardiac potassium current IKr. Nature 1997, 388:289-292.
48. 48 Bianchi L, Shen Z, Dennis AT, et al.: Cellular dysfunction of LQT5-minK mutants: abnormalities of IKs, IKr and trafficking in long QT syndrome. Hum Mol Genet 1999, 8:1499-1507.
49. 49 Gellens M, George AL, Chen L, et al.: Primary structure and functional expression of the human cardiac tetrodotoxin-insensitive voltage-dependent sodium channel. Proc Natl Acad Sci U S A 1992, 89:54-558.
50. 50 George AL, Varkony TA, Drakin HA, et al.: Assignment of the human heart tetrodotoxin-resistant voltage-gated Na channel a-subunit gene (SCN5A) to band 3p21. Cytogenet Cell Genet 1995, 68:67-70.
51. 51 Wang Q, Shen J, Splawski I, et al.: SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 1995, 80:805-811.
52. 52 Wang Q, Shen J, Li Z, et al.: Cardiac sodium channel mutations in patients with long QT syndrome, an inherited cardiac arrhythmia. Hum Mol Genet 1995, 4:1603-1607.
53. 53 Hartmann HA, Colom LV, Sutherland ML, Noebels JL: Selective localization of cardiac SCN5A sodium channels in limbic regions of rat brain. Nat Neurosci 1999, 2:593-595.
54. 54 Bennett PB, Yazawa K, Makita N, George AL Jr: Molecular mechanism for an inherited cardiac arrhythmia. Nature 1995, 376:683-685.
55. 55 Dumaine R, Wang Q, Keating MT, et al.: Multiple mechanisms of sodium channel-linked long QT syndrome. Circ Res 1996, 78:916-992.
56. 56 An RH, Wang XL, Kerem B, et al.: Novel LQT-3 mutation affects Na+ channel activity through interactions between alpha- and beta 1-subunits. Circ Res 1998, 83:141-146.
57. 57 Chen Q, Kirsch GE, Zhang D, et al.: Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 1998, 392:293-296. SCN5A mutations were found to cause Brugada syndrome.
58. 58 Honore E, Attali B, Heurteaux C, et al.: Cloning, expression, pharmacology and regulation of a delayed rectifier K+ channel in mouse heart. EMBO J 1991, 10:2805-2811.
59. 59 Arena JP, Kass RS: Block of heart potassium channels by clofilium and its tertiary analogs: relationship between drug structure and type of channel blocked. Mol Pharmacol 1988, 34:60-66.
60. 60 Vetter DE, Mann JR, Wangemann P, et al.: Inner ear defects induced by null mutation of the isk gene. Neuron 1996, 17:1251-1264.
61. 61 Neyroud N, Tesson F, Denjoy I, et al.: A novel mutation on the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome. Nat Genet 1997, 15:186-189.
62. 62 Splawski I, Timothy KW, Vincent GM, Atkinson DL, Keating MT: Brief report: molecular basis of the long-QT syndrome associated with deafness. N Engl J Med 1997, 336:1562-1567.
63. 63 Chen Q, Zhang D, Gingell RL, et al.: Homozygous deletion in KVLQT1 associated with Jervell and Lange-Nielsen syndrome. Circulation 1999, 99:1344-1347. Homozygous mutations in KVLQT1 shown to cause JLNS.
64. 64 Tyson J, Tranebjaerg L, Bellman S, et al.: IsK and KVLQT1: mutation in either of the two subunits of the slow component of the delayed rectifier potassium channel can cause Jervell and Lange-Nielsen syndrome. Hum Mol Genet 1997, 12:2179-2185.
65. 65 Schulze-Bahr E, Wang Q, Wedekind H, et al.: KCNE1 mutations cause Jervell and Lange-Nielsen syndrome. Nat Genet 1997, 17:267-268.
66. 66 Moss AJ, Zareba W, Benhorin J, et al.: ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation 1995, 92:2929-2934.
67. 67 Zareba W, Moss AJ, Schwartz PJ, et al.: Influence of the genotype on the clinical course of the long-QT syndrome. N Engl J Med 1998, 339:960-965.
68. 68 Li H, Schwartz P, Locati E, Moss A, Robinson J, Towbin JA: Chromosome 11-linked long QT syndrome LQT1 is the most common form of long QT syndrome. Pediatrics 1996, 98:534.
69. 69 Splawski I, Shen J, Timothy KW, Vincent GM, Lehmann MH, Keating MT: Genomic structure of three long QT syndrome genes: KVLQT1, HERG, and KCNE1. Genomics 1998, 51:86-97.
70. 70 Myerburg RJ: Sudden cardiac death in persons with normal (or near normal) heart. Am J Cardiol 1997, 79:3-9.
71. 71 Consensus Statement of the Joint Steering Committees of the Unexplained Cardiac Arrest Registry of Europe and of the Idiopathic Ventricular Fibrillation Registry of the United States: Survivors of out of hospital cardiac arrest with apparently normal heart: need for definition and standardized clinical evaluation. Circulation 1997, 95:265-272.
72. 72 Jouven X, Desnos M, Guerot C, Ducimetiere P: Predicting sudden death in the population: the Paris Prospective Study I. Circulation 1999, 99:1978-1983.
73. 73 Osher HL, Wolff L: Electrocardiographic pattern simulating acute myocardial injury. Am J Med Sci 1953, 226:541-545.
74. 74 Edeiken J: Elevation of RS-T segment, apparent or real in right precordial leads as probable normal variant. Am Heart J 1954, 48:331-339.
75. 75 Levine HD, Wanzer SH, Merrill JP: Dialyzable currents of injury in potassium intoxication resembling acute myocardial infarction or pericarditis. Circulation 1956, 13:29-36.
76. 76 Martini B, Nava A, Thiene G, et al.: Ventricular fibrillation without apparent heart disease: description of six cases. Am Heart J 1989, 118:1203-1209.
77. 77 Aihara N, Ohe T, Kamakura S, et al.: Clinical and electrophysiologic characteristics of idiopathic ventricular fibrillation. Shinzo 1990, 22(suppl 2):80-86.
78. 78 Brugada P, Brugada J: A distinct clinical and electrocardiographic syndrome: right bundle-branch block, persistent ST segment elevation with normal QT interval and sudden cardiac death. PACE 1991, 14:746.
79. 79 Nademanee K, Veerakul G, Nimmannit S, et al.: Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men. Circulation 1997, 96:2595-2600.
80. 80 Gotoh K: A histopathological study on the conduction system of the so-called Pokkuri disease (sudden unexpected cardiac death of unknown origin in Japan). Jpn Circ J 1976, 40:753-768.
81. 81 Hayashi M, Murata M, Satoh M, et al.: Sudden nocturnal death in young males from ventricular flutter. Jpn Heart J 1985, 26:585-591.
82. 82 Naccarella F: Malignant ventricular arrhythmias in patients with a right bundle-branch block and persistent ST segment elevation in V1-V3: a probable arrhythmogenic cardiomyopathy of the right ventricle [ditorial comment]. G Ital Cardiol 1993, 23:1219-1222.
83. 83 Fontaine G: Familial cardiomyopathy associated with right bundle branch block, ST segment elevation and sudden death [letter]. J Am Coll Cardiol 1996, 28:540.
84. 84 Corrado D, Nava A, Buja G, et al.: Familial cardiomyopathy underlies syndrome of right bundle branch block, ST segment elevation and sudden death. J Am Coll Cardiol 1996, 27:443-448.
85. 85 Scheinman MM: Is Brugada syndrome a distinct clinical entity? J Cardiovasc Electrophysiol 1997, 8:332-336.
86. 86 Ohe T: Idiopathic ventricular fibrillation of the Brugada type: an atypical form of arrhythmogenic right ventricular cardiomyopathy [editorial]. Intern Med 1996, 35:595.
87. 87 Fontaine G, Piot O, Sohal P, et al.: Right precordial leads and sudden death: relation with arrhythmogenic right ventricular dysplasia. Arch Mal Coeur Vaiss 1996, 89:1323-1329.
88. 88 Brugada J, Brugada P: Further characterization of the syndrome of right bundle branch block, ST segment elevation, and sudden death. J Cardiovasc Electrophysiol 1997, 8:325-331.
89. 89 Kobayashi T, Shintani U, Yamamoto T, et al.: Familial occurrence of electrocardiographic abnormalities of the Brugada-type. Intern Med 1996, 35:637-640.
90. 90 Gussak I, Antzelevitch C, Bjerregaard P, Towbin JA, Chaitman BR: The Brugada syndrome: clinical, electrophysiological, and genetic considerations. J Am Coll Cardiol 1999, 33:5-15. Extensive review of Brugada syndrome.
91. 91 Antzelevitch C: The Brugada syndrome. J Cardiovasc Electrophysiol 1998, 9:513-516.
92. 92 Suzuki J, Tsubone H, Sugano S: Characteristics of ventricular activation and recovery patterns in the rat. J Vet Med Sci 1992, 54:711-716.
93. 93 Lukas A, Antzelevitch C: Differences in the electrophysiological response of canine ventricular epicardium and endocardium to ischemia: role of the transient outward current. Circulation 1993, 88:2903-2915.
94. 94 Antzelevitch C, Sicouri S, Lukas A, et al.: Clinical implications of electrical heterogeneity in the heart: the electrophysiology and pharmacology of epicardial, M and endocardial cells. In Cardiac Arrhythmia: Mechanism, Diagnosis and Management. Edited by Podrid PJ, Kowey PR. Baltimore: William & Wilkins; 1995:88-107.
95. 95 Litovsky SH, Antzelevitch C: Differences in the electrophysiological response of canine ventricular subendocardium and subepicardium to acetylcholine and isoproterenol: a direct effect of acetylcholine in ventricular myocardium. Circ Res 1990, 67:615-627.
96. 96 Antzelevitch C: Ion channels and ventricular arrhythmias: cellular and ionic mechanisms underlying the Brugada syndrome. Curr Opin Cardiol 1999, 14:274-279. Recent update of the electrophysiology at play in Brugada syndrome.
97. 97 Krishnan SC, Antzelevitch C: Flecainide-induced arrhythmia in canine ventricular epicardium: phase 2 reentry? Circulation 1993, 87:562-572.
98. 98 Krishnan SC, Antzelevitch C: Sodium channel blockade produces opposite electrophysiologic effects in canine ventricular epicardium and endocardium. Circ Res 1991, 69:277-291.
99. 99 Kambouris NG, Nuss HB, Johns DC, Tomaselli GF, Marban E, Balser JR: Phenotypic characterization of a novel long-QT syndrome mutation (R1623Q) in the cardiac sodium channel. Circulation 1998, 97:640-644.
100. 100 Towbin JA: Role of cytoskeletal proteins in cardiomyopathies. Curr Opin Cell Biol 1998, 10:131-139.
101. 101 Towbin JA, Bowles KR, Bowles NE: Etiology of cardiomyopathy and heart failure. Nat Med 1999, 5:266-267. Description of the "final common pathway" hypothesis.